Inhibition of the Growth Factor MDK/Midkine by a Novel Small Molecule Compound to Treat Non-Small Cell Lung CancerHuifang Hao, Yoshio Naomoto|PLoS ONE|2013Cited by 74
Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumorKazufumi Sakurama, Yoshio Naomoto|Molecular Cancer Therapeutics|2009Cited by 68
SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinomaTakuya Fukazawa, Yoshio Naomoto|Scientific Reports|2016Cited by 56
Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma <i>In vitro</i> and <i>In vivo</i>Nobuyuki Watanabe, Yoshio Naomoto|Clinical Cancer Research|2008Cited by 52
Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinomaM. Yoshida, Yoshio Naomoto|Oncotarget|2018Cited by 36